Drug Shortage Report for TOVIAZ
Report ID | 135301 |
Drug Identification Number | 02380048 |
Brand name | TOVIAZ |
Common or Proper name | Toviaz |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | FESOTERODINE FUMARATE |
Strength(s) | 8MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 30's |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-03-19 |
Actual start date | |
Estimated end date | 2021-04-01 |
Actual end date | 2021-03-31 |
Shortage status | Resolved |
Updated date | 2021-04-01 |
Company comments | Limited available inventory is on allocation until depletion on approx March 19th. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-04-01 | English | Compare |
v7 | 2021-03-31 | French | Compare |
v6 | 2021-03-31 | English | Compare |
v5 | 2021-03-25 | French | Compare |
v4 | 2021-03-25 | English | Compare |
v3 | 2021-03-20 | English | Compare |
v2 | 2021-03-08 | French | Compare |
v1 | 2021-03-08 | English | Compare |
Showing 1 to 8 of 8